Ginkgo Bioworks Holdings (DNA) Cash from Operations (2020 - 2026)

Ginkgo Bioworks Holdings has reported Cash from Operations for 7 years, with the latest figure at 46433000.0 in Q1 2026.

• For the quarter ending Q1 2026, Cash from Operations rose 9.88% year-over-year to 46433000.0; the trailing twelve-month figure through Mar 2026 stood at 165971000.0 (up 41.11% YoY), and the FY2025 full-year result was 171059000.0, up 46.47% from the prior year.
• Cash from Operations for Q1 2026 stood at 46433000.0, up from 47678000.0 in the prior quarter.
• The five-year high for Cash from Operations was 19898000.0 in Q1 2022, with the low at 104531000.0 in Q4 2022.
• Historically, Cash from Operations has averaged 63810294.12 across 5 years, with a median of 57831000.0 in 2023.
• Annual changes were most pronounced in 2022 — Cash from Operations slumped 441.76% — and 2025, when it surged 69.46%.
• Ginkgo Bioworks Holdings' Cash from Operations stood at 104531000.0 in 2022, then soared by 44.68% to 57831000.0 in 2023, then gained by 26.62% to 42435000.0 in 2024, then slipped by 12.36% to 47678000.0 in 2025, then increased by 2.61% to 46433000.0 in 2026.
• The last three Cash from Operations figures came in at 46433000.0 (Q1 2026), 47678000.0 (Q4 2025), and 31606000.0 (Q3 2025), per Business Quant data.